Banga Ndzouboukou JL - Search Results

1

Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infections.

Lei Q, Li Y, Hou HY, Wang F, Ouyang ZQ, Zhang Y, Lai DY, Banga Ndzouboukou JL, Xu ZW, Zhang B, Chen H, Xue JB, Lin XS, Zheng YX, Yao ZJ, Wang XN, Yu CZ, Jiang HW, Zhang HN, Qi H, Guo SJ, Huang SH, Sun ZY, Tao SC, Fan XL. Lei Q, et al. Among authors: banga ndzouboukou jl. Allergy. 2021 Feb;76(2):551-561. doi: 10.1111/all.14622. Epub 2020 Oct 26. Allergy. 2021. PMID: 33040337 Free PMC article.

2

Human IgM and IgG Responses to an Inactivated SARS-CoV-2 Vaccine.

Banga Ndzouboukou JL, Zhang YD, Lei Q, Lin XS, Yao ZJ, Fu H, Yuan LY, Fan XL. Banga Ndzouboukou JL, et al. Curr Med Sci. 2021 Dec;41(6):1081-1086. doi: 10.1007/s11596-021-2461-8. Epub 2021 Nov 6. Curr Med Sci. 2021. PMID: 34741251 Free PMC article.

3

Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines.

Zhang Y, Banga Ndzouboukou JL, Gan M, Lin X, Fan X. Zhang Y, et al. Among authors: banga ndzouboukou jl. Front Immunol. 2021 Nov 22;12:771242. doi: 10.3389/fimmu.2021.771242. eCollection 2021. Front Immunol. 2021. PMID: 34880867 Free PMC article. Review.

4

Recent Developments in SARS-CoV-2 Neutralizing Antibody Detection Methods.

Banga Ndzouboukou JL, Zhang YD, Fan XL. Banga Ndzouboukou JL, et al. Curr Med Sci. 2021 Dec;41(6):1052-1064. doi: 10.1007/s11596-021-2470-7. Epub 2021 Dec 21. Curr Med Sci. 2021. PMID: 34935114 Free PMC article. Review.

5

Differential Immunogenicity and Protective Efficacy Elicited by MTO- and DMT-Adjuvanted CMFO Subunit Vaccines against Mycobacterium tuberculosis Infection.

Ullah N, Hao L, Wu Y, Zhang Y, Lei Q, Banga Ndzouboukou JL, Lin X, Fan X. Ullah N, et al. Among authors: banga ndzouboukou jl. J Immunol Res. 2020 Sep 4;2020:2083793. doi: 10.1155/2020/2083793. eCollection 2020. J Immunol Res. 2020. PMID: 32953889 Free PMC article.

6

Helicobacter pylori adhesins: HpaA a potential antigen in experimental vaccines for H. pylori.

Banga Ndzouboukou JL, Lei Q, Ullah N, Zhang Y, Hao L, Fan X. Banga Ndzouboukou JL, et al. Helicobacter. 2021 Feb;26(1):e12758. doi: 10.1111/hel.12758. Epub 2020 Dec 1. Helicobacter. 2021. PMID: 33259676 Review.

7

Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine.

Hao L, Wu Y, Zhang Y, Zhou Z, Lei Q, Ullah N, Banga Ndzouboukou JL, Lin X, Fan X. Hao L, et al. Among authors: banga ndzouboukou jl. Front Immunol. 2020 Sep 30;11:575504. doi: 10.3389/fimmu.2020.575504. eCollection 2020. Front Immunol. 2020. PMID: 33117374 Free PMC article.

8

Label-Free Comparative Proteomics of Differentially Expressed Mycobacterium tuberculosis Protein in Rifampicin-Related Drug-Resistant Strains.

Ullah N, Hao L, Banga Ndzouboukou JL, Chen S, Wu Y, Li L, Borham Mohamed E, Hu Y, Fan X. Ullah N, et al. Among authors: banga ndzouboukou jl. Pathogens. 2021 May 15;10(5):607. doi: 10.3390/pathogens10050607. Pathogens. 2021. PMID: 34063426 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page